Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
25.05
-1.09 (-4.17%)
At close: Dec 9, 2025, 4:00 PM EST
25.03
-0.02 (-0.08%)
After-hours: Dec 9, 2025, 6:55 PM EST
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $1.33 billion as of December 9, 2025. Its market cap has increased by 328.02% in one year.
Market Cap
1.33B
Enterprise Value
1.32B
1-Year Change
328.02%
Ranking
Category
Stock Price
$25.05
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $1.33B, an increase of 270.73%. That is a compound annual growth rate of 20.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 1.33B | 153.80% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |